These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


320 related items for PubMed ID: 29214600

  • 1. Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway.
    Cui L, Bu W, Song J, Feng L, Xu T, Liu D, Ding W, Wang J, Li C, Ma B, Luo Y, Jiang Z, Wang C, Chen J, Hou J, Yan H, Yang L, Jia X.
    Arch Pharm Res; 2018 Mar; 41(3):299-313. PubMed ID: 29214600
    [Abstract] [Full Text] [Related]

  • 2. Alantolactone induces apoptosis in RKO cells through the generation of reactive oxygen species and the mitochondrial pathway.
    Zhang Y, Bao YL, Wu Y, Yu CL, Huang YX, Sun Y, Zheng LH, Li YX.
    Mol Med Rep; 2013 Oct; 8(4):967-72. PubMed ID: 23970102
    [Abstract] [Full Text] [Related]

  • 3. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
    Khan M, Yi F, Rasul A, Li T, Wang N, Gao H, Gao R, Ma T.
    IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
    [Abstract] [Full Text] [Related]

  • 4. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
    Chun J, Li RJ, Cheng MS, Kim YS.
    Cancer Lett; 2015 Feb 01; 357(1):393-403. PubMed ID: 25434800
    [Abstract] [Full Text] [Related]

  • 5. Isoalantolactone induces apoptosis in human breast cancer cells via ROS-mediated mitochondrial pathway and downregulation of SIRT1.
    Li Z, Qin B, Qi X, Mao J, Wu D.
    Arch Pharm Res; 2016 Oct 01; 39(10):1441-1453. PubMed ID: 27600429
    [Abstract] [Full Text] [Related]

  • 6. Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction.
    Khan M, Li T, Ahmad Khan MK, Rasul A, Nawaz F, Sun M, Zheng Y, Ma T.
    Biomed Res Int; 2013 Oct 01; 2013():719858. PubMed ID: 23533997
    [Abstract] [Full Text] [Related]

  • 7. Induction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer Cells.
    Ding Y, Wang H, Niu J, Luo M, Gou Y, Miao L, Zou Z, Cheng Y.
    Int J Mol Sci; 2016 Apr 14; 17(4):558. PubMed ID: 27089328
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanism of apoptosis induction by Gaillardin, a sesquiterpene lactone, in breast cancer cell lines : Gaillardin-induced apoptosis in breast cancer cell lines.
    Fallahian F, Aghaei M, Abdolmohammadi MH, Hamzeloo-Moghadam M.
    Cell Biol Toxicol; 2015 Dec 14; 31(6):295-305. PubMed ID: 26843455
    [Abstract] [Full Text] [Related]

  • 9. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion.
    Wei W, Huang H, Zhao S, Liu W, Liu CX, Chen L, Li JM, Wu YL, Yan H.
    Apoptosis; 2013 Sep 14; 18(9):1060-70. PubMed ID: 23613107
    [Abstract] [Full Text] [Related]

  • 10. Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells.
    Kang X, Wang H, Li Y, Xiao Y, Zhao L, Zhang T, Zhou S, Zhou X, Li Y, Shou Z, Chen C, Li B.
    Artif Cells Nanomed Biotechnol; 2019 Dec 14; 47(1):1961-1970. PubMed ID: 31116036
    [Abstract] [Full Text] [Related]

  • 11. Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer.
    Song J, Shu L, Zhang Z, Tan X, Sun E, Jin X, Chen Y, Jia X.
    Chem Biol Interact; 2012 Jul 30; 199(1):9-17. PubMed ID: 22687635
    [Abstract] [Full Text] [Related]

  • 12. Alantolactone induces apoptosis in THP-1 cells through STAT3, survivin inhibition, and intrinsic apoptosis pathway.
    Ahmad B, Gamallat Y, Su P, Husain A, Rehman AU, Zaky MY, Bakheet AMH, Tahir N, Xin Y, Liang W.
    Chem Biol Drug Des; 2021 Feb 30; 97(2):266-272. PubMed ID: 32780548
    [Abstract] [Full Text] [Related]

  • 13. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway.
    He W, Cao P, Xia Y, Hong L, Zhang T, Shen X, Zheng P, Shen H, Zhao Y, Zou P.
    Free Radic Res; 2019 Jan 30; 53(1):104-114. PubMed ID: 30668191
    [Abstract] [Full Text] [Related]

  • 14. Alantolactone induces activation of apoptosis in human hepatoma cells.
    Lei JC, Yu JQ, Yin Y, Liu YW, Zou GL.
    Food Chem Toxicol; 2012 Sep 30; 50(9):3313-9. PubMed ID: 22721982
    [Abstract] [Full Text] [Related]

  • 15. Alantolactone induces apoptosis and suppresses migration in MCF‑7 human breast cancer cells via the p38 MAPK, NF‑κB and Nrf2 signaling pathways.
    Liu J, Liu M, Wang S, He Y, Huo Y, Yang Z, Cao X.
    Int J Mol Med; 2018 Oct 30; 42(4):1847-1856. PubMed ID: 30015828
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity of alantolactone in lung cancer cell lines NCI-H1299 and Anip973.
    Liu J, Yang Z, Kong Y, He Y, Xu Y, Cao X.
    J Food Biochem; 2019 Sep 30; 43(9):e12972. PubMed ID: 31489665
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-κB pathways.
    He Y, Cao X, Kong Y, Wang S, Xia Y, Bi R, Liu J.
    Hum Exp Toxicol; 2019 Oct 30; 38(10):1132-1144. PubMed ID: 31203647
    [Abstract] [Full Text] [Related]

  • 18. Isocostunolide, a sesquiterpene lactone, induces mitochondrial membrane depolarization and caspase-dependent apoptosis in human melanoma cells.
    Chen CN, Huang HH, Wu CL, Lin CP, Hsu JT, Hsieh HP, Chuang SE, Lai GM.
    Cancer Lett; 2007 Feb 08; 246(1-2):237-52. PubMed ID: 16697106
    [Abstract] [Full Text] [Related]

  • 19. Ambrosin sesquiterpene lactone exerts selective and potent anticancer effects in drug-resistant human breast cancer cells (MDA-MB-231) through mitochondrial mediated apoptosis, ROS generation and targeting Akt/β-Catenin signaling pathway.
    Fan S, Cui Y, Hu Z, Wang W, Jiang W, Xu H.
    J BUON; 2020 Feb 08; 25(5):2221-2227. PubMed ID: 33277839
    [Abstract] [Full Text] [Related]

  • 20. Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells.
    Xu X, Huang L, Zhang Z, Tong J, Mi J, Wu Y, Zhang C, Yan H.
    Life Sci; 2019 Jun 15; 227():153-165. PubMed ID: 31004657
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.